RT Book, Section A1 Rose, Mary A1 Robert, Rhonda A2 Duffy, James D. A2 Valentine, Alan D. SR Print(0) ID 1125785620 T1 Interface between Psychiatry, Sleep, and Cancer T2 MD Anderson Manual of Psychosocial Oncology YR 2016 FD 2016 PB McGraw-Hill Education PP New York, NY SN 9780071624381 LK hemonc.mhmedical.com/content.aspx?aid=1125785620 RD 2024/11/02 AB Overwhelmingly, cancer patients report sleepiness as well as fatigue as among the most disabling side effects they experienced following cancer and its treatment. Approximately 30% to 60% of all cancer patients report sleep disturbance as a significant problem,1,2 with long-term cancer survivors being 40% more likely than the normative population to experience distress.3 At time of treatment, distress is even more significant; of those sampled with the Hamilton Anxiety Depression Scale in a general oncology waiting room in Argentina, 74.9% surpassed the cutoff score for anxiety, depression, or both.4 In another study of US patients awaiting chemotherapy, depression and anxiety were prevalent, with 45% of those sampled endorsing sleep disturbance.5